(Q39916149)

English

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox (English)

1 reference

Europe PubMed Central

15 September 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

15 September 2017

object named as

Ulrich Kalinke

10

0 references

2

object named as

Yasemin Suezer

1 reference

Europe PubMed Central

15 September 2017

Astrid Schwantes

5

object named as

Astrid Schwantes

1 reference

Europe PubMed Central

15 September 2017

6

object named as

Sharon Melamed

1 reference

Europe PubMed Central

15 September 2017

7

object named as

Lior Katz

1 reference

Europe PubMed Central

15 September 2017

3

object named as

Shlomo Lustig

1 reference

Europe PubMed Central

15 September 2017

Avigdor Shafferman

15

object named as

Avigdor Shafferman

1 reference

Europe PubMed Central

15 September 2017

author name string

Nir Paran

1

1 reference

Europe PubMed Central

15 September 2017

Tomer Israely

4

1 reference

Europe PubMed Central

15 September 2017

Thomas Preuss

8

1 reference

Europe PubMed Central

15 September 2017

Kay-Martin Hanschmann

9

1 reference

Europe PubMed Central

15 September 2017

Noam Erez

11

1 reference

Europe PubMed Central

15 September 2017

Reuven Levin

12

1 reference

Europe PubMed Central

15 September 2017

Baruch Velan

13

1 reference

Europe PubMed Central

15 September 2017

Johannes Löwer

14

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

15 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

15 September 2017

199

1 reference

Europe PubMed Central

15 September 2017

1

1 reference

Europe PubMed Central

15 September 2017

39-48

1 reference

Europe PubMed Central

15 September 2017

The looming threat of bioterrorism

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Developing new smallpox vaccines

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Obligatory requirement for antibody in recovery from a primary poxvirus infection

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Correlates of protective immunity in poxvirus infection: where does antibody stand?

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Respiratory infection of mice with vaccinia virus

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Ectromelia virus: the causative agent of mousepox

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

An antigenic difference between intracellular and extracellular rabbitpox virus

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Inactivated Smallpox Vaccine: Immunogenicity of Inactivated Intracellular and Extracellular Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Cell-mediated cytotoxicity in recovery from poxvirus infections

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Induction of natural killer cell responses by ectromelia virus controls infection

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses

1 reference

https://api.crossref.org/works/10.1086%2F595565

21 January 2018

Identifiers

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39916149&oldid=1984677424"